NASDAQ:FTRE Fortrea (FTRE) Stock Price, News & Analysis $22.78 +0.36 (+1.61%) Closing price 04:00 PM EasternExtended Trading$22.80 +0.02 (+0.11%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Fortrea Stock (NASDAQ:FTRE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Fortrea alerts:Sign Up Key Stats Today's Range$22.31▼$23.5550-Day Range$16.79▼$22.7552-Week Range$8.55▼$23.55Volume2.38 million shsAverage Volume1.67 million shsMarket Capitalization$2.17 billionP/E Ratio37.37Dividend YieldN/APrice Target$22.80Consensus RatingHold Company Overview Fortrea Holdings Inc. is a global contract research organization (CRO) that provides services to pharmaceutical, biotechnology and medical device companies. The company supports the development and commercialization of healthcare products across a range of therapeutic areas. Its services include clinical trial management, study design, patient recruitment and engagement, data management, biostatistics, regulatory support, medical affairs and post-approval services. Fortrea also provides technology-enabled and decentralized clinical trial solutions intended to help sponsors conduct research across traditional and remote settings. Fortrea serves customers internationally, with operations and clinical trial capabilities spanning North America, Europe, Asia-Pacific and other global markets. The company was established in 2023 following the separation of Labcorp’s clinical development business and is headquartered in Durham, North Carolina.AI Generated. May Contain Errors. Read More Fortrea Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreFTRE MarketRank™: 2.5 of 5 starsFortrea scored higher than 50% of companies evaluated by MarketBeat, and ranked 587th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingFortrea has received a consensus rating of Hold. The company's average rating score is 2.42, and is based on no strong buy ratings, 7 buy ratings, 3 hold ratings, and 2 sell ratings.Upside/DownsideThe consensus price target for Fortrea is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageFortrea has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Fortrea's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth18.82% Earnings GrowthEarnings for Fortrea are expected to grow by 18.82% in the coming year, from $0.85 to $1.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fortrea is -25.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fortrea is -25.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioFortrea has a PEG Ratio of 0.59. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioFortrea has a P/B Ratio of 3.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Fortrea's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.31% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in Fortrea has recently increased by 0.11%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFortrea does not currently pay a dividend.Dividend GrowthFortrea does not have a long track record of dividend growth. News and Social Media3.2 / 5News Sentiment0.15 News SentimentFortrea has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Fortrea this week, compared to 4 articles on an average week.Search Interest2 people have searched for FTRE on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows2 people have added Fortrea to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Fortrea insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,917,635.00 in company stock.Percentage Held by Insiders0.73% of the stock of Fortrea is held by insiders.Percentage Held by InstitutionsFortrea has minimal institutional ownership at this time.Read more about Fortrea's insider trading history. Receive FTRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FTRE Stock News HeadlinesFortrea Completes $45 Mln Acquisition Of Worldwide's Early Phase Services DivisionsOctober 20 at 8:20 AM | rttnews.comFortrea Holdings Inc: Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical TrialsOctober 19 at 7:35 PM | finanznachrichten.deFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.October 20 at 1:00 AM | Weiss Ratings (Ad)Is Fortrea Holdings (FTRE) Still Cheap After Its 116% Run?October 19 at 7:35 PM | finance.yahoo.comFortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical TrialsOctober 19 at 4:05 PM | globenewswire.comDeutsche Bank Upgrades Fortrea to Buy From Hold, $25 Price TargetOctober 15, 2026 | finance.yahoo.comFortrea : How China's regulatory evolution is accelerating rare disease drug developmentOctober 13, 2026 | marketscreener.comMFortrea (NASDAQ:FTRE) Stock Rating Upgraded by Wall Street ZenOctober 10, 2026 | americanbankingnews.comSee More Headlines FTRE Stock Analysis - Frequently Asked Questions How have FTRE shares performed this year? Fortrea's stock was trading at $17.25 at the start of the year. Since then, FTRE stock has increased by 32.1% and is now trading at $22.78. How were Fortrea's earnings last quarter? Fortrea Holdings Inc. (NASDAQ:FTRE) issued its quarterly earnings data on Wednesday, July, 29th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.18 by $0.05. The company had revenue of $678.20 million for the quarter, compared to analyst estimates of $647.57 million. Fortrea had a positive trailing twelve-month return on equity of 10.72% and a negative net margin of 3.18%. Read the conference call transcript. Who are Fortrea's major shareholders? Fortrea's top institutional shareholders include Ausbil Investment Management Ltd (0.18%), Assenagon Asset Management S.A. (0.08%), State of Alaska Department of Revenue (0.02%) and Krilogy Financial LLC (0.02%). Insiders that own company stock include Anshul Thakral, Thomas Pike, Peter M Neupert, Jill G Mcconnell, Robert Parks, James S Hanson, Erin L Russell and Carrie Elizabeth Russell. View institutional ownership trends. How do I buy shares of Fortrea? Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Fortrea own? Based on aggregate information from My MarketBeat watchlists, some other companies that Fortrea investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Intel (INTC), Micron Technology (MU), Qualcomm (QCOM), Freeport-McMoRan (FCX) and Corning (GLW). Company Calendar Last Earnings7/29/2026Today10/20/2026Next Earnings (Estimated)10/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 FTRE's financial health is in the Green zone, according to TradeSmith. FTRE has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:FTRE CIK1965040 Webwww.fortrea.com Phone877-495-0816FaxN/AEmployees14,300Year Founded2023Price Target and Rating Average Price Target for Fortrea$22.80 High Price Target$26.00 Low Price Target$16.00 Potential Upside/Downside+0.1%Consensus RatingHold Rating Score (0-4)2.42 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($0.91) Trailing P/E RatioN/A Forward P/E Ratio26.80 P/E Growth0.59Net Income-$986.20 million Net Margins-3.18% Pretax Margin-2.91% Return on Equity10.72% Return on Assets2.17% Debt Debt-to-Equity Ratio1.98 Current Ratio0.96 Quick Ratio0.96 Sales & Book Value Annual Sales$2.72 billion Price / Sales0.80 Cash Flow$10.04 per share Price / Cash Flow2.27 Book Value$6.10 per share Price / Book3.73Miscellaneous Outstanding Shares95,100,000Free Float94,406,000Market Cap$2.17 billion OptionableOptionable Beta1.93 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NASDAQ:FTRE) was last updated on 10/20/2026 by MarketBeat.com Staff. From Our PartnersTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredBuy These Five AI Plays Before October 20Jeff Brown, founder and CEO of Brownstone Research, says a new market cycle he calls the million dollar cycle ...Brownstone Research | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredPalantir and Wall Street are in on it…Palantir just signed a major AI deal with a company most investors have never heard of. Wall Street has pou...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
